General MedicationsTRANSDERMALGeneric
OXYBUTYNIN CHLORIDE
OXYBUTYNIN CHLORIDE
Standard Dose
10% (100MG/PACKET)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview OXYBUTYNIN CHLORIDE is listed in Drugs@FDA under application 207329 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient OXYBUTYNIN CHLORIDE Form and strength GEL;TRANSDERMAL - 10% (100MG/PACKET) Sponsor CHARTWELL RX Submission history Latest submission status date: 2018-05-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview OXYBUTYNIN CHLORIDE is listed in Drugs@FDA under application 207329 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient OXYBUTYNIN CHLORIDE Form and strength GEL;TRANSDERMAL - 10% (100MG/PACKET) Sponsor CHARTWELL RX Submission history Latest submission status date: 2018-05-31 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.